✦ LIBER ✦

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

✍ Scribed by Wagner, U; Marth, C; Largillier, R; Kaern, J; Brown, C; Heywood, M; Bonaventura, T; Vergote, I; Piccirillo, M C; Fossati, R; Gebski, V; Lauraine, E P

Book ID: 118033873
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 242 KB
Volume: 107
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2012.307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin and pegylated liposomal doxo

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

✍ Gladieff, L.; Ferrero, A.; De Rauglaudre, G.; Brown, C.; Vasey, P.; Reinthaller, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 124 KB

18LBA A GCIG randomized phase III study

18LBA A GCIG randomized phase III study of carboplatin (C) & pegylated liposomal doxorubicin (PLD) (C-D) vs carboplatin (C) & paclitaxel (P) (C-P): CALYPSO results in partially platinum-sensitive ovarian cancer (OC) patients

✍ P. Vasey; R. Largillier; M. Gropp; V. Gebski; R. Sandvei; L. Elit; L. Angleitner 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Single agent carboplatin versus carbopla

Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial

✍ Maurie Markman; James Moon; Sharon Wilczynski; Ana Maria Lopez; Kendrith M. Rowl 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Phase II trial of carboplatin and distea

Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox®) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum

✍ Sheng-Mou Hsiao; Chi-An Chen; Ho-Hsiung Lin; Chang-Yao Hsieh; Lin-Hung Wei 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 166 KB

A randomized phase II study of carboplat

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

✍ Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimit 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 332 KB

Epirubicin/paclitaxel/carboplatin (TEC)

Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO stages IIB–IV. Results of a randomized AGO-GINECO GCIG Intergroup phase III trial

✍ E. PUJADE-LAURAINE; A. du BOIS; A. GOUPIL; J. ROCHON; V. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB